newsfilter
← Latest News
Business Wire·

Infinity Pharmaceuticals Appoints Robert Ilaria, Jr., M.D., as Chief Medical Officer and Brian Schwartz, M.D., to Its Board of Directors

– Experienced leader in immuno-oncology drug development Robert Ilaria, Jr. to head eganelisib clinical development – – Brian Schwartz, M.D., transitioning from Consulting Chief Physician to Infinity's Board of Directors – Infinity Pharma